Influence of body composition and muscle strength on outcomes after multimodal esophageal cancer treatment
File(s)Fig2.png (95.02 KB)
Supporting information
Author(s)
Type
Journal Article
Abstract
Background:
Influence of sarcopenia in combination with other body composition parameters and muscle strength on outcomes after esophageal surgery for esophageal cancer remains unclear. The objectives were to: 1. Describe the incidence of sarcopenia in relation to adipose tissue quantity and distribution and muscle strength. 2. To evaluate if neoadjuvant chemoradiation (nCRTx) influences body composition and muscle strength. 3. To evaluate the influence of body composition and muscle strength on postoperative morbidity and long-term survival.
Methods:
This retrospective study included patients with esophageal cancer who received nCRTx followed by surgery between January 2011 and 2016. Skeletal muscle, visceral and subcutaneous adipose tissue cross sectional areas were calculated based on CT scans and muscle strength was measured using hand grip tests, 30 seconds chair stand tests and maximal inspiratory and expiratory pressure tests prior to nCRTx and after nCRTx.
Results:
A total of 322 patients were included in this study. Sarcopenia was present in 55.6% of the patients prior to nCRTx and in 58.2% after nCRTx (p=0.082). Patients with sarcopenia had a significantly lower muscle strength and higher fat percentage. The muscle strength and incidence of sarcopenia increased whilst the mean BMI and fat percentage decreased during nCRTx. A BMI above 25 kg/m2 was associated with anastomotic leakage (p=0.032). Other body composition parameters were not associated with postoperative morbidity. A lower handgrip strength prior to nCRTx was associated with pulmonary and cardiac complications (p=0.023 and p=0.009 respectively). In multivariable analysis, a lower number of stands during the 30 seconds chair stand test prior to nCRTx (HR 0.93, 95%CI 0.87 – 0.99, p=0.017) and visceral adipose tissue of >128 cm2 after nCRTx (HR 1.81, 95%CI 1.30 – 2.53, p=0.001) were associated with worse overall survival.
Conclusion:
Sarcopenia occurs frequently in patients with esophageal cancer and is associated with less muscle strength and a higher fat percentage. Body composition changes during nCRT did not influence survival. Impaired muscle strength and a high amount of visceral adipose tissue are associated with worse survival. Therefore, patients with poor fitness might benefit from preoperative nutritional and muscle strengthening guidance, aiming to increase muscle strength and decrease visceral adipose tissue. However, this should be confirmed in a large prospective study.
Influence of sarcopenia in combination with other body composition parameters and muscle strength on outcomes after esophageal surgery for esophageal cancer remains unclear. The objectives were to: 1. Describe the incidence of sarcopenia in relation to adipose tissue quantity and distribution and muscle strength. 2. To evaluate if neoadjuvant chemoradiation (nCRTx) influences body composition and muscle strength. 3. To evaluate the influence of body composition and muscle strength on postoperative morbidity and long-term survival.
Methods:
This retrospective study included patients with esophageal cancer who received nCRTx followed by surgery between January 2011 and 2016. Skeletal muscle, visceral and subcutaneous adipose tissue cross sectional areas were calculated based on CT scans and muscle strength was measured using hand grip tests, 30 seconds chair stand tests and maximal inspiratory and expiratory pressure tests prior to nCRTx and after nCRTx.
Results:
A total of 322 patients were included in this study. Sarcopenia was present in 55.6% of the patients prior to nCRTx and in 58.2% after nCRTx (p=0.082). Patients with sarcopenia had a significantly lower muscle strength and higher fat percentage. The muscle strength and incidence of sarcopenia increased whilst the mean BMI and fat percentage decreased during nCRTx. A BMI above 25 kg/m2 was associated with anastomotic leakage (p=0.032). Other body composition parameters were not associated with postoperative morbidity. A lower handgrip strength prior to nCRTx was associated with pulmonary and cardiac complications (p=0.023 and p=0.009 respectively). In multivariable analysis, a lower number of stands during the 30 seconds chair stand test prior to nCRTx (HR 0.93, 95%CI 0.87 – 0.99, p=0.017) and visceral adipose tissue of >128 cm2 after nCRTx (HR 1.81, 95%CI 1.30 – 2.53, p=0.001) were associated with worse overall survival.
Conclusion:
Sarcopenia occurs frequently in patients with esophageal cancer and is associated with less muscle strength and a higher fat percentage. Body composition changes during nCRT did not influence survival. Impaired muscle strength and a high amount of visceral adipose tissue are associated with worse survival. Therefore, patients with poor fitness might benefit from preoperative nutritional and muscle strengthening guidance, aiming to increase muscle strength and decrease visceral adipose tissue. However, this should be confirmed in a large prospective study.
Date Issued
2020-06-01
Date Acceptance
2020-01-07
Citation
Journal of Cachexia, Sarcopenia and Muscle, 2020, 11 (3), pp.756-767
ISSN
2190-6009
Publisher
Wiley Open Access
Start Page
756
End Page
767
Journal / Book Title
Journal of Cachexia, Sarcopenia and Muscle
Volume
11
Issue
3
Copyright Statement
© 2020 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of Society on Sarcopenia, Cachexia and Wasting Disorders. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made (https://creativecommons.org/licenses/by-nc-nd/4.0/).
Subjects
Science & Technology
Life Sciences & Biomedicine
Geriatrics & Gerontology
Medicine, General & Internal
General & Internal Medicine
Oesophageal cancer
Body composition
Sarcopenia
Muscle strength
Complications
Survival
SKELETAL-MUSCLE
SARCOPENIC OBESITY
NEOADJUVANT CHEMOTHERAPY
COMPUTED-TOMOGRAPHY
VISCERAL ADIPOSITY
PROGNOSTIC-FACTOR
MASS INDEX
CHEMORADIOTHERAPY
SURVIVAL
CACHEXIA
Body composition
Complications
Muscle strength
Oesophageal cancer
Sarcopenia
Survival
0606 Physiology
1103 Clinical Sciences
1106 Human Movement and Sports Sciences
Publication Status
Published
Date Publish Online
2020-02-25